ISDS Case Map
intellectual property
The Trans-Pacific Partnership Agreement reportedly contains provisions that would lead to higher drug prices, not just in the TPPA but in future trade agreements as well, UNAIDS warns.
TPP would violate the right of US states to protection from suit for patent, trademark or copyright infringement
As the negotiations for the Trans-Pacific Partnership Agreement (TPPA) enter what could be its last round, we as people living with HIV/Aids (PLHIV), urge the Malaysian government not to trade away our lives.
Oone issue that has received comparatively little attention is how the Trans-Pacific Partnership is likely to impact the developing countries slated to join.
Experts say the government should carefully consider before signing free-trade agreements (FTA) - as people could be hurt by deals that prolong drug patents and restrict information about medicine.
A draft of the Trans-Pacific Partnership's "Intellectual Property" chapter from May 11, 2015 has recently been leaked to journalists and contains significant change on intermediary liability rules compared to previous leaks.
New Zealand needs to be ready to walk away from the Trans Pacific Partnership, says The Domion Post, worried about the impact of its drug patenting rules and investor-state dispute settlement mechanism.
A recent draft of the Trans-Pacific Partnership free-trade deal would give US pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in US law.
Recently leaked documents show that India’s policies on software and pharmaceutical patents are firmly on the RCEP agenda.
NZ is heading towards a two-tier health system, and it could get a whole lot worse, writes George Laking.
